Want to see HK:7630 full AI Analyst Report?
IMPACT Therapeutics, Inc. Class H (7630) Financial Statements
IMPACT Therapeutics, Inc. Class H Financial Overview
IMPACT Therapeutics, Inc. Class H's market cap is currently $2.40B. The company's EPS TTM is $-0.13; its P/E ratio is -8.21; IMPACT Therapeutics, Inc. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 5.33M | $ 4.68M | $ 33.27M |
| Gross Profit | $ 4.49M | $ 3.54M | $ 32.14M |
| Operating Income | $ -32.04M | $ -28.98M | $ -4.00M |
| EBITDA | $ -31.42M | $ -26.86M | $ -1.60M |
| Net Income | $ -41.23M | $ -35.54M | $ 519.73K |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 36.99M | $ 46.59M | $ 38.95M |
| Total Assets | $ 47.86M | $ 53.26M | $ 43.65M |
| Total Debt | $ 123.32M | $ 118.21M | $ 0.00 |
| Net Debt | $ 86.33M | $ 86.70M | $ -38.95M |
| Total Liabilities | $ 184.92M | $ 155.18M | $ 57.10M |
| Stockholders' Equity | $ -137.06M | $ -101.93M | $ -13.45M |
| Cash Flow | |||
| Free Cash Flow | $ -13.57M | $ -12.28M | $ 3.06M |
| Operating Cash Flow | $ -13.36M | $ -12.05M | $ 3.10M |
| Investing Cash Flow | $ 15.68M | $ -57.18M | $ 17.68M |
| Financing Cash Flow | $ 1.92M | $ 62.55M | $ 5.59M |
Currency in USD